Does Inclusion of Viral Prescription Pad Resources Increase Responsiveness to Feedback About Antibiotic Prescribing in Primary Care
- Disease/Condition
- Infection
- Drug/Device/Intervention
- Emphasis on the Choosing Wisely Viral Prescription Pad
- Study type
- Interventional
- Intervention type
- behavioral
- Primary sponsor
- Women's College Hospital
- Location
- Toronto, Canada
- Phase
- N/A
- Start date
- Dec 15, 2021
- End date
- Dec 30, 2022
- Enrollment
- 4000 participants
Antibiotic prescribing rate
Antibiotic overuse is common and antibiotic prescribing contributes to rising rates of
 antimicrobial resistance. Primary care physicians prescribe the majority of all antibiotics
 and there is large inter-physician variability in prescribing that cannot be explained by
 differences in patient populations.
 
 In Ontario, audit and feedback (A&F) is routinely offered to primary care providers from a
 variety of sources. Ontario Health - an agency created by the Government of Ontario -
 provides A&F via email to physicians who voluntarily sign up for their MyPractice reports.
 These are multi-topic reports with aggregated (physician-level) data. As of November 2021,
 the MyPractice reports for family physicians will include data on antibiotic prescribing. To
 date, less than half of Ontario family physicians have signed up for the MyPractice reports
 from Ontario Health.
 
 For this study, the investigators will conduct a trial to investigate the effect of adding
 viral prescription pad resources to family physician A&F received through a MyPractice:
 Primary Care report. This evaluation provides an opportunity to determine if the addition of
 this resource to an A&F intervention increases changes to antibiotic prescribing.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05044052
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT05044052 through Pure Global AI's free database. This phase not specified trial is sponsored by Women's College Hospital and is currently Enrolling by invitation. The study focuses on Infection. Target enrollment is 4000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.